GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cambridge Nutritional Sciences CNSL.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

1.55p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Cambridge Nutritional Sciences — daily CNSL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Cambridge Nutritional Sciences on TradingView ↗
Market value
£3.7m
Last close × shares
Volume
200.5k
Shares, 9 Nov 2026

About Cambridge Nutritional Sciences

Its shares trade on LSE under the ticker CNSL.L. It has been listed since 18 March 2004. In the fiscal year to 31 March 2026, it reported revenue of £7.0m and a net loss of £5.8m. At that date it held total assets of £7.4m and shareholders' equity of £5.7m.

Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The company is headquartered in Alva, Stirlingshire. The company went IPO on 2004-03-18. The firm's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. The company offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.

Figures and description from our data supplier, not checked against the company's own report.

More about Cambridge Nutritional Sciences →

Latest on Cambridge Nutritional Sciences

Our reporting

We have not reported on Cambridge Nutritional Sciences yet.

Next results

10 Nov 2026

Due on 10 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Cambridge Nutritional Sciences's ticker?

Cambridge Nutritional Sciences trades as CNSL.L on LSE, under ISIN GB00B1VCP282.

What was Cambridge Nutritional Sciences's last closing price?

1.55p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Cambridge Nutritional Sciences next report results?

Results are expected on 10 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.